Rigel
corporate overview

pipeline

investors & media

careers



 press release archive

press release archive

Current | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997


12/12/2006 Rigel’s R788 Shows Promise for Treating B-Cell Lymphoma and Leukemia in Preclinical Studies
11/7/2006 Rigel Announces Third Quarter 2006 Financial Results
10/17/2006 Rigel Announces Selection of R348, A Novel JAK3 Inhibitor, For Advanced Preclinical Development
10/5/2006 Rigel Announces Upcoming Presentation at the 14th International Inflammation Research Association (IRA) Conference
9/19/2006 Rigel Announces Initiation of Phase I Study Evaluating R763 in Solid Tumors
9/6/2006 Rigel Announces Initiation of Phase II Study Evaluating R788 in Rheumatoid Arthritis
8/31/2006 Rigel Announces Presentations at Three Investor Conferences
8/2/2006 Rigel Announces Second Quarter 2006 Financial Results
7/21/2006 Rigel Announces Upcoming Presentation at the 2006 Controlled Release Society (CRS) Annual Meeting
7/19/2006 Rigel’s Janus Kinase 3 (JAK3) Inhibitors Show Benefit in Organ Transplant Model and Potential Use in Immunosuppression
6/21/2006 Rigel Announces Presentations at the 2006 Targeting Ubiquitin for Drug Discovery and Development Conference
6/13/2006 Rigel and Merck Collaboration Progress Triggers Milestone Payments from Merck in Ligase Partnership
6/7/2006 Rigel Announces Presentations at Two Investor Conferences
6/6/2006 Rigel Names Ryan D. Maynard Vice President of Finance
5/17/2006 Rigel Announces Pfizer Selection of R343, a Syk Kinase Inhibitor, for Advanced Preclinical Development in Allergic Asthma
5/10/2006 Rigel to Present at Bank of America Annual Healthcare Conference on May 17th, 2006
5/3/2006 Rigel to Present at Upcoming Scientific Conferences
5/2/2006 Rigel Announces First Quarter 2006 Financial Results
4/19/2006 Rigel Announces Presentations at Two Investor Conferences
4/4/2006 Rigel to Present at the BIO 2006 Annual International Convention
3/22/2006 Rigel Announces Upcoming Presentation on Axl at the 2006 American Association of Cancer Research (AACR) Annual Meeting
3/21/2006 Rigel Granted Key Patents in Immunology, Virology and Oncology
3/1/2006 Rigel to Present at Ninth Annual Lehman Brothers Global Healthcare Conference
2/22/2006 Rigel Announces Completion of R788 plus Methotrexate Drug Interaction Study in Patients with Rheumatoid Arthritis
2/8/2006 Rigel to Present at BIO CEO & Investor Conference 2006
2/7/2006 Rigel Announces Fourth Quarter and Year End 2005 Financial Results
2/1/2006 Rigel to Present at Upcoming Scientific Conferences
1/30/2006 Rigel Achieves Milestone with Merck Ligase Collaboration
1/26/2006 Rigel To Receive $5 Million Milestone Payment from Serono for R763
1/4/2006 Rigel to Present at Upcoming Keystone Symposia
© 2013 Rigel  |  privacy  |  disclaimer | Follow Us On:    contact us  |  site map  |  search    Search